Mushroom Guru · Strand, Western Cape · Updated November 2026

MG-LZ8™
Scientific Evidence

Seven independent laboratories. Eight years of continuous analytical documentation. One breakthrough extract — independently verified at every level of the quality chain.

Verve Dynamics Inqaba Genomics University of Louisville Stellenbosch Univ. CAF Mérieux NutriSciences Neogen / Megazyme Ecogreen Analytics

Every number on this page documents the same thing, that MG-LZ8™ does not add something artificial to your biology. It removes what is preventing your biology from working — the interference that buries the signal your body already knows how to read. What follows is eight years of independent analytical evidence of how comprehensively, and how verifiably, it does that. Buckle up!

MG-LZ8™ is the proprietary dual-phase extract of Ganoderma sichuanense Zhao & Zhang, cultivated in antler morphology at Mushroom Guru’s Strand facility. MG-LZ8™ is in a category of its own: we have yet to find any other company that has published a comparable antler triterpenoid profile. Species identity has been confirmed by dual-marker genomic sequencing. Immune activity has been measured in an independent pre-clinical study in mice at the University of Louisville. Compound profile, purity, and extraction consistency have been independently verified, with seven independent laboratories contributing data in total. The cultivation methodology has been documented in a supervised thesis at the University of the Free State. All data on this page is sourced from original third-party laboratory documents held on file.
1

Species Identity &
Genomic Confirmation

Species confirmed as Ganoderma sichuanense Zhao & Zhang (= G. lingzhi) by independent genomic sequencing

Inqaba Biotechnical Industries (Pty) Ltd conducted dual-marker ITS and EF1-alpha sequencing of the MG-LZ8™ source culture. ITS region: 99.69% identity match. EF1-alpha region: 100% identity match. GenBank accession numbers OR685549.1 (ITS) and JX029974.1 (EF1-alpha) provide independently verifiable links to deposited reference sequences at NCBI.

MarkerIdentity MatchGenBank AccessionSpecies Confirmed
ITS Region99.69%OR685549.1G. sichuanense (= G. lingzhi)
EF1-alpha Region100%JX029974.1G. sichuanense (= G. lingzhi)

The same analysis confirmed a commercially available product from a high-profile international mycology supplier as Ganoderma sessile — a taxonomically distinct North American species — misidentified as G. lucidum in that product's labelling.

Source: Inqaba Biotechnical Industries (Pty) Ltd. Fungal Identification Report SA2025/195735. Analysed 01 August 2025. Reviewed by Dr E Viljoen (Genomics Scientist) and Dr C Labuschagne (Genomics Manager). Pretoria, South Africa.
2

Pre-Clinical
Immunological Validation

238×IL-2 cytokine increase (single 100 μg dose, mice)Větvička 2018
+51.7%Phagocytosing neutrophils at 24 hours — from 31.1% baseline to 47.2%Větvička 2018
NoneSignificant effect on the growth of four cancer cell lines at all doses tested — 48 hoursVětvička 2018

Measurable innate and adaptive immune response in mice, with no effect on cancer cell growth

Prof. Vaclav Větvička, Department of Pathology, University of Louisville, Kentucky USA — one of the world's leading researchers in beta-glucan immunology — conducted an independent, commissioned pre-clinical study of MG-LZ8™ in 2018.

Prof. Větvička scaled the mouse doses (50 and 100 μg per mouse) from the 15 mg human dose, and the immune response rose with dose across both. At the 100 μg dose, IL-2 production increased from 1.1 pg/ml to 262.4 pg/ml (238-fold), and at 24 hours phagocytosing neutrophils (the first-responder immune cells) increased from 31.1% baseline to 47.2% (+51.7%). In cell culture at 48 hours, the extract showed no significant effect on the growth of four cancer cell lines (MCF-7, HL-60, NCI-H23, PC-3) at any dose tested.

Prof. Větvička’s conclusion: “From these experiments it is clear that the sample designed MG-LZ8 is a biologically active sample with significant effects on immune reactions. In addition, the sample showed no toxic effects towards cells in vitro.”

Source: Větvička V. Immunological Effects of MG-LZ8™ Extract. Independent commissioned pre-clinical report. Department of Pathology, University of Louisville, Kentucky, USA. Final Report: 8 September 2018.
3

Compound Profile &
Comparative Analysis

Two benchmarks, side by side: MG-LZ8™, the antler benchmark (~13:1), and the internationally recognised 16:1 conk dual-extract benchmark. Each carries the triterpenoid signature of its own morphology.

In October 2021, MG-LZ8™ was analysed side by side with the internationally recognised 16:1 conk dual-extract benchmark under identical LC-MS/QTOF conditions. The mass spectrometry was performed by Prof. Marietjie Stander at the Central Analytical Facility (CAF), Stellenbosch University; the written report was compiled by Dr. T. Little of Raluka Biotech.

Both extracts are rich in triterpenoids, and the distribution between them differs. MG-LZ8™ carries higher proportions of ganoderic acid B, ganoderic acid C2, DHTLO and the compound at RT 28.5; the conk extract carries more ganoderic acids A, D and F and ganoderenic acid B. Two compounds set the antler extract apart: GA/B (RT 32.17) at 8.07% against 0.14% in the conk extract, and a compound at RT 25.84 detected in MG-LZ8™ only.

Percentages below are relative proportions of the most abundant compounds in each sample, not concentrations. Compound identities are provisional pending full MS/MS fragmentation. A three-way run comparing FS-19, MG-LZ8™ and a fresh conk benchmark sample is under way with Prof. Stander; the results will be added here.

CompoundConk Benchmark 16:1 (%)MG-LZ8™ (%)MG-LZ8™ vs conk
Ganoderic Acid A (GA)17.7316.13−9%
Ganoderic Acid B (GB)7.008.40+20%
Ganoderic Acid D (GD)11.008.68−21%
12-Acetoxyganoderic Acid F8.816.97−21%
Ganoderenic Acid B (GEB)9.755.29−46%
DHTLO5.667.05+25%
Ganoderic Acid C2 (GC2)4.976.03+21%
GA/B (RT 32.17)0.148.07Antler marker (conk near detection limit)
Unknown (RT 28.5)3.915.51+41%
Unknown (RT 25.84)Not detected3.07MG-LZ8™ only
Source: Prof. M. Stander, Central Analytical Facility (CAF), Stellenbosch University (performed the LC-MS/QTOF analysis); Dr. T. Little, Raluka Biotech (report compiler). MS/QTOF Comparative Report v1.2. October 2021.
4

β-Glucan
Quantification

β-glucan confirmed at 9.10% w/w (low heat extract) in MG-LZ8™ finished extract by Megazyme K-YBGL assay

9.10%β-glucan w/w — pure, finished extractK-YBGL / Megazyme 2023
10.89%Total glucan w/wK-YBGL / Megazyme 2023
1.79%Alpha-glucan w/wK-YBGL / Megazyme 2023

The Neogen/Megazyme K-YBGL assay was applied to MG-LZ8™ finished extract (sample H23-25401). At 9.10% beta-glucan in a 15mg capsule, MG-LZ8™ delivers 1.37mg beta-glucan per dose. The same run confirmed the 16:1 conk extract at 20.31% beta-glucan (which confirms a high-heat process). The 9.10% reflects the controlled, low-temperature, dual-phase extract. FS-19, the tri-phase upgrade, adds a high-heat stage to recover more glucans; it is being tested by Prof. Marietjie Stander, and a second Megazyme run will complete its glucan profile.

Source: Neogen Corporation / Megazyme. Mega-Calc™ Data Calculator. β-Glucan (Yeast & Mushroom) (K-YBGL) Determination. Sample: Mushroom Guru H231011-09, identifier H23-25401. Printed 31 October 2023.
5

Purity, Safety
& Heavy Metals

Starch below detection limit. Glucose the only sugar present.

SANAS-accredited laboratory Mérieux NutriSciences (accreditation T0350) conducted a full purity and safety analysis of MG-LZ8™ in October 2023.

ParameterResultLimit / Significance
Starch<0.50g/100g (below detection)Confirms zero grain substrate contamination
Total fat25.6g/100gConsistent with a retained lipid-soluble fraction
Glycaemic carbohydrates2.71g/100g (glucose only)Confirms absence of starch-derived carbohydrate load
Source: Mérieux NutriSciences. Certificate of Analysis N° 1803559-0. SANAS-accredited laboratory T0350. Signed: Aluwani Nedohe, Technical Signatory. October 2023.
Verve Dynamics — Whole Antler Heavy Metals (July 2017)+

Heavy metals confirmed well below international limits at raw material stage

Heavy MetalResultInternational LimitMargin
Lead0.171 ppm<3.0 ppm17.5× below limit
Cadmium0.018 ppm<1.0 ppm55× below limit
Mercury0.002 ppm<0.10 ppm50× below limit
Source: Davies RP. Certificate of Analysis, Lot DV MGLZ8-WH: 01-07/17. Verve Dynamics Laboratory, Somerset West. Signed 22 July 2017. Method AOAC 984.27.
6

Extraction Methodology
& Consistency

29× extraction multiplier confirmed by independent HPLC. 12× antler-morphology triterpenoid density confirmed by expert chromatographic interpretation.

Verve Dynamics Laboratory (R.P. Davies, Somerset West) conducted independent HPLC comparative analysis in July 2017. The ethanolic only extract showed a 29-fold increase in total triterpenoid content compared to raw antler material. Expert chromatographic interpretation of the antler vs standard conk comparison found approximately 12-fold higher triterpenoid concentration in the antler form.

A breakthrough in Ganoderma extraction

MG-LZ8™ is the product of two innovations working together: antler-morphology cultivation, which harvests the mushroom at its triterpenoid-rich developmental stage, and Mushroom Guru’s proprietary controlled, low-temperature, dual-phase extraction, refined over 13 years.

The finished extract is concentrated at approximately 13:1 (batch range 12.8–13.9:1). That is a tighter ratio than the 16:1 conk benchmark, because the starting material is already richer: an extraction ratio measures how much raw material goes in, not how much active compound comes out.

Combined cascade: 12 × 29 = 348×

One 15mg capsule of MG-LZ8™ delivers the triterpenoid equivalent of approximately 5,220mg of standard imported Reishi powder.

The 12× and 29× are independent, compounding factors: 12× is a powder-to-powder morphological comparison (antler vs conk); 29× is the extraction multiplier applied to that richer starting material.

Source: Davies RP. HPLC Comparative Analysis. Verve Dynamics Laboratory. July 2017. Direct quotation on file: “Sample 4 had a 29-fold increase in total triterpenoid content when compared to Sample 1 after being extracted with ethanol.”

Extraction Philosophy: Biological Activity Beyond Glucan Content

MG-LZ8™ is developed around a research-led extraction philosophy that prioritises the characterisation and biological activity of the finished extract, rather than maximising a single compositional marker.

The process uses a controlled, low-temperature extraction stage. One objective is to limit unnecessary heat exposure of potentially heat-sensitive constituents, including proteins. Whether intact LZ-8 protein is retained, and whether it remains biologically active in the finished extract, requires product-specific analytical and functional verification.

Glucan content remains an important compositional measurement, but it is not, by itself, a complete measure of an extract’s biological activity. Mushroom Guru is investigating how extraction conditions influence glucan recovery, protein preservation, chemical composition and biological responses.

This approach distinguishes measurable composition from demonstrated biological activity and recognises that the significance of an extract ultimately requires appropriate experimental validation.

Extraction Consistency Verification — Ecogreen Analytics (February 2025)+

In-house extraction profile met and improved on the original Verve Dynamics validated baseline

Following technology transfer and in-house extraction implementation, Ecogreen Analytics (Gregory Ondrejkovic) independently verified that the current MG-LZ8™ in-house extraction profile met and improved on the original Verve Dynamics validated triterpenoid profile. This confirms the successful transfer of the extraction to Mushroom Guru’s own GMP-audited facility in Strand.

Source: (the late, and sorely missed) G. Ondrejkovic, Ecogreen Analytics. Certificate of Analysis, Lab ID JB25-029-01. February 2025.
7

Academic Replication of the
MG-LZ8™ Antler Cultivation Approach

The antler cultivation approach underlying MG-LZ8™ has been recreated under the guidance of Mushroom Guru at the University of the Free State (UFS) as part of master’s research. The work addressed antler formation, cultivation conditions and the developmental stage at harvest.

Miss C. Van der Berg, under the supervision of Prof. B.C. Viljoen (Department of Microbial, Biochemical and Food Biotechnology, University of the Free State), used a Mushroom Guru tissue culture (UFS-GL1) as the founding culture. The Mushroom Guru elevated CO₂ antler induction protocol was reproduced under controlled academic conditions, and antler formation was confirmed within 28 days. Craig Fourie’s prior research on lignocellulosic substrate conversion via Ganoderma mycelium (Fourie, 2015) is cited as primary academic literature within the thesis.

The UFS research concerned cultivation and antler development; it did not reproduce Mushroom Guru’s proprietary extraction process. The extraction technology used to produce MG-LZ8™ remains distinct from the cultivation methodology investigated in the academic research.

The published master’s research provides an academic reference for the cultivation and developmental aspects of the process.

Source: Van der Berg C (2019). Industrial and medicinal application of Reishi and Lion’s Mane mushrooms. B.Sc. Microbiology (M.Sc.) thesis. University of the Free State. Supervisor: Prof. B.C. Viljoen. UFS Ref: 2011040272.
8

Laboratory
Verification Summary

LaboratoryKey FindingDate
Verve Dynamics (R.P. Davies)
Somerset West, South Africa
12× antler-morphology triterpenoid density confirmed. 29× extraction cascade confirmed by HPLC. Dual-phase CoAs issued with full heavy metals and microbiological panels.July 2017
University of Louisville
Prof. Vaclav Větvička, Department of Pathology, Kentucky, USA
Independent commissioned pre-clinical study in mice (50 and 100 μg per mouse). At the 100 μg dose: IL-2 up 238-fold, and phagocytosing neutrophils up 51.7% at 24 hours. In his words, “a biologically active sample with significant effects on immune reactions.” No significant effect on the growth of four cancer cell lines at 48 hours.Sep 2018
Stellenbosch University CAF
Prof. Marietjie Stander (performed the mass spectrometry);
Dr. T. Little, Raluka Biotech (report compiler)
11 specific triterpenoid compounds identified. Side by side with the internationally recognised 16:1 conk dual-extract benchmark: a distinct antler signature, with GA/B at 8.07% against 0.14% and a compound found in MG-LZ8™ only.May & Oct 2021
Mérieux NutriSciences
SANAS-accredited T0350
Starch below detection limit. Glucose the only sugar detected. Full nutritional profile, including fat, protein, fibre and fatty acids.Oct 2023
Neogen / Megazyme K-YBGLβ-glucan confirmed at 9.10% w/w (low-temperature, dual-phase extract) using industry-standard K-YBGL method. Same run confirmed the conk benchmark at 20.31%.Oct 2023
Inqaba Biotechnical Industries
Pretoria, South Africa
Species identity confirmed as G. sichuanense Zhao & Zhang (= G. lingzhi). ITS: 99.69%. EF1-alpha: 100%. GenBank accessions OR685549.1 and JX029974.1 provide independently verifiable reference links at NCBI. Inqaba notes that G. sichuanense and G. lingzhi are considered the same species, G. sichuanense being the accepted older name.Aug 2025
Ecogreen Analytics
Gregory Ondrejkovic
In-house extraction met and improved on the original Verve Dynamics validated triterpenoid profile, confirming successful technology transfer to the Mushroom Guru GMP-audited facility in Strand.Feb 2025
9

The Antler
Developmental Biology

The antler is not a stress response — it is the mushroom’s natural exploration state, activated by a single environmental signal

Ganoderma sichuanense carries two fully encoded developmental programs in its genome. Which one runs is determined by a single environmental signal: the ratio of CO₂ to oxygen in the immediate atmosphere.

When CO₂ is elevated — as it is underground, inside decaying wood, or in a sealed cultivation environment — the organism activates its exploration program. In the most recent transcriptomic study of elevated CO₂, 5,913 genes changed expression across the study, with almost 3,000 changing in a single fruiting-body comparison (Fang et al., 2026). It grows vertically, elongating and sending structures upward to find oxygen. The reproductive program is held in reserve.

The moment oxygen is detected as the growing tip reaches open air, the signal reverses. The antler program is downregulated. The pileus begins to form, spore production begins, and the organism transitions from exploration to reproduction. The genome study of G. lucidum found triterpenoid content extremely low in mycelium, at its highest in the primordium and falling as the mature fruiting body forms, with 78 triterpenoid-pathway genes switching on before fruiting and off after it (Chen et al., 2012).

Antler Phase — Exploration Program

Elevated CO₂ signal active. Organism growing vertically toward oxygen. Full secondary metabolite biosynthesis running. Triterpenoid content at its developmental peak (Chen et al., 2012). Reproductive switch held in reserve.

Conk Phase — Reproductive Program

Oxygen signal received. Antler program downregulated. Pileus formation begins. Biological resources redirected from secondary metabolite production to spore production and reproduction. Triterpenoid density falls.

Mushroom Guru harvests exclusively at the antler stage — before the oxygen signal reverses the developmental program.

Supporting literature: Chen S et al. (2012). Genome sequence of the model medicinal mushroom Ganoderma lucidum. Nature Communications 3:913. Fang T et al. (2026). Combined Transcriptomic and Metabolomic Analyses of the Response of Ganoderma lucidum to Elevated CO₂. Journal of Fungi 12:5. Van der Berg C (2019). UFS Ref 2011040272.
10

Glyconutrient Profile —
The Communication Layer

MG-LZ8™ contains five of the eight essential saccharides required for immune cell communication — confirmed by independent laboratory analysis

Research by Dr. Steve Nugent identified eight monosaccharides required for the glycoprotein structures on cell surfaces that govern immune cell-to-cell communication. Modern diets typically provide only two of these eight.

✓
MannoseConfirmed
✓
GlucoseConfirmed
✓
GalactoseConfirmed
✓
FucoseConfirmed
✓
XyloseConfirmed
N-Acetylglucosamine, N-Acetylgalactosamine, N-Acetylneuraminic acid — not assessed in current analytical suite

Mannose and fucose are of particular immunological significance. Mannose engages the mannose receptor CD206 on macrophages and dendritic cells. Fucose is a key component of the selectin-ligand structures that govern immune cell migration and tissue homing.

The LZ-8 immunomodulatory protein — the first mushroom immune protein ever characterised, isolated from Ganoderma — has a structure with functional homology to the Fc domain of human immunoglobulins.

Sources: Davies RP, Verve Dynamics Laboratory. Analysis confirming mannose, fucose, xylose, glucose, galactose. July 2017. Nugent SR. Glyconutrient framework. Hsu H-Y et al. Multiple publications on LZ-8 immunomodulatory protein. 2003–2020.
11

Clinical Translation —
What the Data Means in Practice

Laboratory numbers translated into clinical and formulation relevance

Laboratory FindingClinical / Formulation Relevance
IL-2 238-fold increase
(Větvička, 2018)
IL-2 is the primary cytokine governing T-cell proliferation and immune surveillance. A 238-fold rise signals strong adaptive immune activation, through the beta-glucan / Dectin-1 pathway that mice and humans share.
Phagocytosing neutrophils +51.7% at 24 hoursNeutrophils are the body’s first-responder cells. A +51.7% rise in phagocytosis within 24 hours indicates a markedly more active innate response.
No significant effect on four cancer cell lines at any doseThe extract neither stimulated nor inhibited cancer cell growth in culture. In Prof. Větvička’s words, the sample “showed no toxic effects towards cells in vitro.”
Starch below detection limit.For formulators: clean label calculations, no hidden carbohydrate load. For practitioners: suitable for low-carbohydrate or grain-free protocols.
15mg dose — 348× concentration cascadeFor formulators: 585mg+ of capsule space remains after a full 15mg MG-LZ8™ serving in a standard size 00 capsule, leaving room for co-ingredients.
GA/B compound (RT 32.17) — detected in MG-LZ8™, near detection limit in the comparatorIdentity is provisional pending full MS/MS fragmentation. For pharmaceutical partners: a research opportunity worth characterising.
Five saccharides confirmed — including mannose and fucoseMannose engages CD206 on macrophages and dendritic cells. Fucose supports selectin-ligand structures governing immune cell migration. Both absent from most supplement formats.

Research in Progress

MG-LZ8™ is the subject of proposed clinical research with South African academic partners. Practitioners interested in research collaboration are invited to make contact directly; the full research brief is available on request.

Analytical documentation, sample quantities, and practitioner pricing available on request.
MG-LZ8™ is selective about the formulations and protocols it enters.

Request documentation or samples

Original laboratory reports, sample quantities, practitioner pricing, and formulator briefs available to authorised practitioners, formulators, and regulatory parties on request.

Request documentation or samples →
You’ve seen the evidence

The body is not broken.
Here is what to do next.

Every laboratory finding on this page points to the same outcome. A body that has what it needs to work. Reishi has been used in Traditional Chinese Medicine for over two thousand years to support immune function and resilience; MG-LZ8™ delivers it as beta-glucans and triterpenoids with immunomodulatory properties. MG-LZ8™ is the starting point — not another supplement to add to the stack, but the biological foundation that makes everything else possible.

01
Start with the capsule

The GanodermaGOLD™ Immune Modulator is the cleanest entry point. 15mg per capsule. 348× triterpenoid equivalent. The MG-LZ8™ extract has no fillers, no chitin, no alcohol and starch below detection; each capsule carries it in cassava root inside a plant-based shell. One capsule daily — the full 15mg serving in a single step.

Shop the range →
02
Follow a protocol

The Personal Protocol is a structured 12-week framework built around MG-LZ8™ — covering supplementation, nutrition, movement, and sleep. The same protocol Craig and Nikki Fourie completed in 2023. Results documented.

View the Personal Protocol →
03
Find it near you

GanodermaGOLD™ is stocked across South Africa. Health shops, practitioners, and specialist retailers in all major provinces. If you prefer to buy in person, find your nearest stockist.

Find a stockist →
MG-LZ8™ does not do the work for you. It gives your body back the conditions it needs to do the work itself. Back to MG-LZ8™ →
Declaration & Regulatory Notice

All data on this page is sourced from original third-party laboratory reports held on file by Mushroom Guru (Pty) Ltd. All referenced test results were produced by independent, accredited, or university-affiliated laboratories. Original source documents are available to authorised practitioners, formulators, and regulatory parties on request.

MG-LZ8™ is a validated bioactive extract under ongoing scientific investigation. GanodermaGOLD™ products are Category D complementary medicines (D 33.4 Traditional Chinese Medicine). This unregistered medicine has not been evaluated by SAHPRA for its quality, safety or intended use.

Craig Fourie — Founder & Director, Mushroom Guru (Pty) Ltd
33 years cultivation experience  |  13 years Ganoderma sichuanense cultivation and dual-phase extraction refinement
Mushroom Guru (Pty) Ltd  |  Reg. 2014/075567/07  |  Strand, Western Cape, South Africa